Lv4
556 积分 2022-09-23 加入
Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy
15天前
已完结
In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177
15天前
已完结
Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors
15天前
已完结
Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer
15天前
已完结
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu
1个月前
已完结
Comparative Saturation Binding Analysis of 64Cu-Labeled Somatostatin Analogues Using Cell Homogenates and Intact Cells
2个月前
已完结
Enzymological Characterization of 64Cu-Labeled Neprilysin Substrates and Their Application for Modulating the Renal Clearance of Targeted Radiopharmaceuticals
2个月前
已完结
Enhancing Cytosolic Internalization of [177Lu]Lu–iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule
2个月前
已完结
Preclinical Development and Evaluation of Uricase mRNA-Loaded Lipid Nanoparticles for the Treatment of Hyperuricemia
2个月前
已完结
Preclinical Development and Evaluation of Uricase mRNA-Loaded Lipid Nanoparticles for the Treatment of Hyperuricemia
2个月前
已完结
皖公网安备34019202002308
